Article
Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population.
EBioMedicine - 1 Feb 2022
Kang Xiaoying, Jiao Tong, Wang Haiyang, Pernow John, Wirdefeldt Karin
Abstract excerpt
BACKGROUND: Tumor necrosis factor (TNF) is a potent inflammatory cytokine that has been causally associated with coronary artery disease (CAD) and ischemic stroke (IS), implying opportunities for disease prevention by anti-TNF therapeutics. METHODS: Leveraging summary statistics of several genome-wide association studies (GWAS), we assessed the repurposing potential of TNF inhibitors for CAD and IS using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
